Cohance Lifesciences (NSE:COHANCE, BOM:543064) has an average rating of overweight and mean price target of 394.88 Indian rupees, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
KE (BEKE) has an average rating of buy and mean price target of $21.20, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Venture Global (VG) has an average rating of overweight and mean price target of $15.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
MasTec (MTZ) has an average rating of buy and mean price target of $488.40, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)